L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU)

Cancer. 1977 Jun;39(6 Suppl):2883-903. doi: 10.1002/1097-0142(197706)39:6<2883::aid-cncr2820390676>3.0.co;2-9.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma, Mucinous / drug therapy
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / surgery
  • Carcinoma, Intraductal, Noninfiltrating / drug therapy
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Female
  • Fluorouracil / therapeutic use*
  • Humans
  • Leukopenia / chemically induced
  • Lymphatic Metastasis
  • Mastectomy
  • Melphalan / adverse effects
  • Melphalan / therapeutic use*
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Prospective Studies
  • Thrombocytopenia / chemically induced

Substances

  • Melphalan
  • Fluorouracil